Variant #0000985293 (NC_000006.11:g.161127501A>G, NM_000301.3:c.112A>G (PLG))
Individual ID |
00449810 |
Chromosome |
6 |
Allele |
Both (homozygous) |
Affects function (as reported) |
Affects function |
Affects function (by curator) |
Affects function |
Classification method |
ACMG |
Clinical classification |
pathogenic (recessive) |
DNA change (genomic) (Relative to hg19 / GRCh37) |
g.161127501A>G |
DNA change (hg38) |
g.160706469A>G |
Published as |
K19E |
ISCN |
- |
DB-ID |
PLG_000017 See all 5 reported entries |
Variant remarks |
tPA-mediated activation assays could predict the clinical outcome for Lys38Glu carriers, but fibrin-independent uPA-mediated assays could not: p.Lys38Glu variant is likely not to be able to efficiently engage fibrin, with a subsequent short half-life. Lys19 is a very conserved residue among primates. One possible mechanism for plasminogen deficiency resulting from Lys to Glu substitution could be its location in the N-terminus region. In Glu1-PLG, p.Lys38Glu variant may lead to a relaxed conformational state, which is easier to activate and degrade. |
Reference |
Journal: Tefs 2006 Journal: Bourrienne 2020 |
ClinVar ID |
ClinVar-RCV000014551.38 |
dbSNP ID |
rs73015965 |
Origin |
Germline |
Segregation |
yes |
Frequency |
0.00282 |
Re-site |
- |
VIP |
- |
Methylation |
- |
Average frequency (gnomAD v.2.1.1) |
0.00289 View details |
Owner |
Christian Drouet |
Database submission license |
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International |
Created by |
Christian Drouet |
Date created |
2024-05-16 12:01:37 +02:00 (CEST) |
Date last edited |
2024-05-16 12:36:23 +02:00 (CEST) |

Variant on transcripts
Screenings
|
Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.
|